Mitochondrial respiratory chain super-complex I–III in physiology and pathology  by Lenaz, Giorgio et al.
Biochimica et Biophysica Acta 1797 (2010) 633–640
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbab ioReview
Mitochondrial respiratory chain super-complex I–III in physiology and pathology
Giorgio Lenaz a, Alessandra Baracca a, Giovanna Barbero a, Christian Bergamini a, Maria Elena Dalmonte a,
Marianna Del Sole a, Marco Faccioli a, Anna Falasca b, Romana Fato a,
Maria Luisa Genova a,⁎, Gianluca Sgarbi a, Giancarlo Solaini a
a Dipartimento di Biochimica, Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy
b Dipartimento di Scienze Farmacologiche, Biologiche e Chimiche applicate, Università di Parma, V.le Usberti 27/A, 43100 Parma, ItalyAbbreviations: BHM, Beef Heart Mitochondria; BN-PA
Gel Electrophoresis; CL, Cardiolipin; Cn, Metabolic Flux
Ubiquinone; mtDNA, mitochondrial DNA; OXPHOS, Oxid
POM, Potato Tuber Mitochondria; RLM, Rat Liver Mitoch
Species; SDS-PAGE, Sodium Dodecyl-Sulfate Polyacrylami
⁎ Corresponding author. Tel.: +39 051 2091214; fax:
E-mail address: marialuisa.genova@unibo.it (M.L. Ge
0005-2728/$ – see front matter © 2010 Elsevier B.V. A
doi:10.1016/j.bbabio.2010.01.025a b s t r a c ta r t i c l e i n f oArticle history:
Received 3 December 2009
Received in revised form 20 January 2010
Accepted 20 January 2010
Available online 30 January 2010
Keywords:
Mitochondria
Super-complex
Flux control
Channeling
Complex IRecent investigations by native gel electrophoresis showed the existence of supramolecular associations of
the respiratory complexes, conﬁrmed by electron microscopy analysis and single particle image processing.
Flux control analysis demonstrated that Complex I and Complex III in mammalian mitochondria kinetically
behave as a single unit with control coefﬁcients approaching unity for each component, suggesting the
existence of substrate channeling within the super-complex. The formation of this supramolecular unit
largely depends on the lipid content and composition of the inner mitochondrial membrane. The function of
the super-complexes appears not to be restricted to kinetic advantages in electron transfer: we discuss
evidence on their role in the stability and assembly of the individual complexes, particularly Complex I,
and in preventing excess oxygen radical formation. There is increasing evidence that disruption of the
super-complex organization leads to functional derangements responsible for pathological changes, as we
have found in K-ras-transformed ﬁbroblasts.GE, Blue Native Polyacrylamide
Coefﬁcient; CoQ, Coenzyme Q,
ative Phosphorylation System;
ondria; ROS, Reactive Oxygen
de Gel Electrophoresis
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Themitochondrial respiratory chainwasﬁrst described as a sequence
of prosthetic groups (ﬂavins and cytochromes) embedded in a protein
matrix in the inner mitochondrial membrane, transferring electrons in
the order of increasing redox potential [1], and subsequently as the
functional sequence of four major multi-subunit complexes, randomly
dispersed in the membrane, and designated as NADH–Coenzyme Q
reductase (Complex I, CI), succinate–CoQ reductase (Complex II, CII),
ubiquinol–cytochrome c reductase (Complex III, CIII) and Cytochrome c
oxidase (Complex IV, CIV); in this latter view, the enzyme complexes are
connected by two mobile redox-active molecules, i.e. a lipophilic qui-
none, designated Coenzyme Q (CoQ) or ubiquinone, embedded in the
membrane lipid bilayer, and a hydrophilic heme protein, cytochrome c
(cyt. c), localized on the external surface of the inner membrane [2].
Some evidence against a random distribution of respiratory com-
plexes was already available by analysis of the early investigations
reporting isolation of Complex I–Complex III [3] and Complex II–
Complex III units [4,5] and suggesting that such units may be preferen-
tially associated in the native membrane. Further data on the presenceof stable associations of Complex III and IV isolated from some bacteria
[6–8] as well as circumstantial evidence on the existence of OXPHOS
assemblies [9,10] was usually overlooked by subsequent studies.
Much more recently, new evidence of multi-complex units in
yeast and mammalian mitochondria was produced by Blue Native
Polyacrylamide Gel Electrophoresis (BN-PAGE) for the isolation of
membrane protein complexes [11–13].
Inbovine heartmitochondria (BHM)Complex I–III interactionswere
apparent from the presence of about 17% of total Complex I arranged in
the form of the I1III2 super-complex while the majority of Complex I
(67%)was found assembled into super-complexes (respirasomes) com-
prising dimeric Complex III and different copy numbers of Complex IV.
Only 14–16% of total Complex I was found in free form in the
presence of digitonin [13], so it seems likely that all Complex I is
bound to Complex III in physiological conditions. Moreover, since the
two complexes occur in a 1:3 average stoichiometry in mammalian
mitochondria [13], it is plausible that approximately one-third of total
Complex III is not bound to monomeric Complex I. Two-dimensional
gels of mitochondria from beef heart, rat liver and potato tuber (Fig. 1)
show the presence of respiratory super-complexes in both animal and
plant mitochondria.
2. Molecular structure of super-complex I–III
A well deﬁned architecture was observed for all super-complexes
thatwere investigated, supporting the ideaofhighly orderedassociations
of the respiratory super-complexes and not of random aggregates, thus
Fig. 1. Two-dimensional electrophoretic separation of OXPHOS supercomplexes. Digitonin-solubilized mitochondrial proteins from beef heart (left), rat liver (center) and potato
tuber (right) were previously resolved by 1D BN-PAGE (shown only for BHM, upper lane) and then loaded on 2D SDS-PAGE gel. After electrophoresis, the whole gel was transferred
onto nitrocellulose and submitted to immunoblotting with monoclonal antibodies speciﬁc for single subunits of the OXPHOS complexes (MitoSciences Inc., Eugene, OR, USA) and to
chemiluminescent detection (ECLTM Detection Kit, GE Healthcare Europe GmbH), as highlighted in the picture: NDUFA9 (39 kDa) of Complex I, Rieske protein (22 kDa, apparent
molecular weight is 30 kDa) and Core I (47 kDa) of Complex III, COX-I (57 kDa, apparent molecular weight is 35 kDa) and COX-IV (18 kDa) of Complex IV, cytochrome c (12 kDa).
The Coomassie blue-stained bands in the 1D lane of BHM were indentiﬁed on the basis of the molecular mass scale, labeled by numbers 146–1236 (Native MarkTM , LC0725,
Invitrogen), and of their protein subunit composition as assessed by the corresponding spots in the immunoblot. SC, high molecular weight assemblies, super-complexes.
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available to date, it appears that such interactions may be species- or
kingdom-speciﬁc [14].
Three-dimensional models of the I1III2 super-complex isolated
from plant and mammalian mitochondria [15–17] were generated
by comparison of the 2D projection map of the super-complex, as
revealed by Electron Microscopy analysis (EM) and single particle
image processing, with known EM and X-ray structures of Complex I
and Complex III. The speciﬁc orientation observed for the two
respiratory-chain complexes indicates an interaction within the
plane of the membrane whereas the matrix-exposed protein domains
are in one another's vicinity but probably do not (strongly) interact.
However, the apparent interaction between the two complexes
may be different in Arabidopsis [15] and in a bovine super-complex
consisting of Complex I, dimeric Complex III and Complex IV (I1III2IV1)
where positions and orientations of all the individual complexes were
determined in detail [17]; in the plant structure Complex III attaches
to the end of the membrane arm of Complex I, whereas Schäfer et al.
[17,18] suggested that the surface interaction is more extensive in the
bovine super-complex showing Complex III and IV respectively
associated with the middle and the terminal portion of the membrane
arm of Complex I, and in contact with each other. On the basis of the
structural information gained from the 3D map [17], the putative
mobile electron carrier (CoQ or cytochrome c) binding site of each
complex is facing the corresponding binding site of the succeeding
complex in the respiratory chain, supporting the notion of a more
efﬁcient electron transfer through the super-complex due to the short
diffusion distances of substrates. Two-dimensional projection struc-
tures were also reported for super-complexes III–IV from yeast [19].
It has been also proposed [19,20] that the OXPHOS complexes may
be further organized in (row-like) mega-complexes or respiratory
strings composedby super-complexes asbuildingblocks,which seem to
be important for themorphology of the innermitochondrialmembrane.
3. Role of super-complexes in substrate channeling
A recent study [21] conﬁrmed the presence of different forms of
super-complexes in mouse liver mitochondria, some also containingComplex II and ATP synthase. Respiration was measured with a Clark
electrode in protein bands of high molecular weight excised from BN-
PAGE stripes, showing full respiratory activity from either NADH or
succinate, which was sensitive to the speciﬁc respiratory inhibitors of
all involved complexes. Interestingly, excised bands of individual
complexes were unable to support integrated electron transfer when
mixed together.
The demonstration that super-complexes are capable of respira-
tion is not however sufﬁcient to demonstrate if they are a necessary
prerequisite for respiratory activity and if they provide a kinetic
advantage over electron transfer based on random collisions. Our
laboratory has produced evidence for a functional role of the I–III
super-complex in substrate channeling in the CoQ region [22–24].
Metabolic ﬂux control analysis allows a quantitative measurement
of the control exerted on a composite pathway by its individual
enzymatic steps [25,26]. It is assumed by the theory of this analysis
that the control would be differently exerted by one or more steps
in the pathway, and that the sum of the control coefﬁcients of all
steps would approach 1, and not overcome unity, if the individual
steps consist of separate enzymes joined by the diffusion of common
intermediates.
The situation would be different, however, in enzymatic super-
complexes where the interactions between active sites are ﬁxed and
substrates and intermediates are channeled from one deﬁned site to
another one without leaving the protein environment; in such a
super-complex, the metabolic pathway would behave as a single
enzyme unit, and inhibition of any one of the enzyme components
would elicit the same ﬂux control. In a system inwhich the respiratory
chain is totally dissociated from other components of the OXPHOS
apparatus (ATP synthase, membrane potential, and carriers), such as
open non-phosphorylating submitochondrial particles, the existence
of a super-complex would elicit a ﬂux control coefﬁcient near unity at
any of the respiratory complexes, and the sum of all apparent coefﬁ-
cients would be times above 1, depending on the number of addends
[27].
The ﬂux control coefﬁcients of the respiratory complexes were
investigated in bovine heart mitochondria and submitochondrial
particles devoid of substrate permeability barriers by performing
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and III were found to be highly rate-controlling over NADH oxidation
(CI=1.1, CIII=1.0), a strong kinetic evidence suggesting the existence
of a functionally relevant association between the two complexes. On
the contrary, Complex IV functionally behaves as being randomly
distributed (CIV=0.3); since Complex IV of mammalianmitochondria
is structurally found also in super-complexes (Section 1), it is likely
that cytochrome c exhibits pool behavior because it is not a stable part
of the super-complex; it is also possible that Complex IV association
escapes kinetic detection due to a pronounced abundance of
molecules in non-assembled form.
At difference, in permeabilized mitochondria from freshly har-
vested potato tubers (POM), titration experiments indicate that
Complex I and Complex III are involved in the formation of a super-
complex assembly also comprising Complex IV molecules (CI=0.9,
CIII=1.1, CIV=1.2).
We have also obtained kinetic evidence of a super-complex I–III
functional assembly in mitochondria under phosphorylating condi-
tions (state 3 NAD-dependent respiration) by exploiting ﬂux control
analysis in freshly prepared liver mitochondria from old rats (RLM)
where, being respiration rate-limiting over other accessory activities
because of aging, wewere able to detect high control by both Complex
I and Complex III [35].
4. Kinetic properties of super-complex I–III
We have investigated the kinetic properties of the I–III super-
complex in order to answer the following questions:
(a) What are the determinants of Complex I association with
Complex III?
(b) Is super-complex formation strictly required for electron
transfer from NADH to cytochrome c?
(c) If not, what are the kinetic advantages, if any, of the association
of Complex I to Complex III in comparison with random
distribution of both complexes and “pool” behavior of CoQ?
We have addressed the problem in proteoliposomes.
A mitochondrial fraction enriched in Complex I and Complex III
[29] was reconstituted with different amounts of phospholipids and
CoQ10 [30] to discriminate whether the respiratory complexes behave
as individual enzymes (CoQ-pool behavior) or as assembled super-
complexes depending on the experimental distances between the
intramembrane particles. The comparison of the experimentally
determined NADH–cyt. c reductase activity with the values expected
by theoretical calculation applying the pool equation of Kröger and
Klingenberg [31] showed overlapping results at 1:10 (w:w) phos-
pholipid dilution and further, i.e. for theoretical distances >50 nm
assuming random distribution of the complexes, whereas at shorter
distances between Complex I and Complex III, resembling the mean
nearest neighbor distance between respiratory complexes in mito-
chondria [32,33], pool behavior was not effective anymore [30,34,35].
In two experimental models of reconstitution, at protein to phospho-
lipid ratio 1:30 and 1:1, kinetic testing according to the Metabolic ﬂux
Control Analysis validated the hypothesis of a random organization in
the former and of a functional association between Complex I and
Complex III in the latter [35]. BN-PAGE conﬁrmed that the fraction
having high protein to lipid ratio was strongly enriched in the I–III
super-complex whereas the relative amount of bound complexes
compared to their free form appeared drastically diminished in the
fraction having high phospholipid content (Fig. 2), as suggested by
densitometric results for selected paired spots in the gel patterns
(i.e. Complex I bound/free=20 vs. 0.4 and Complex III bound/free=1 vs.
0.3, respectively in the 1:1 and 1:30 samples).
Wehave also demonstrated byﬂux control analysis [34,35] that the
maintenance of the I–III super-complex in proteoliposomes at high
protein to lipid ratios (see above) is abolished if lipid peroxidation isinduced by 2,2′-azobis-(2-amidinopropane) dihydrochloride (AAPH)
before reconstitution. Evidently, the distortion of the lipid bilayer
induced by peroxidation and the consequent alteration of the tightly
bound phospholipids determine dissociation of the super-complex
originally present in the lipid-poor preparation.
The results of the above investigations allow us to reach the
following conclusions:
(a) The basic determinant of super-complex I–III formation by
speciﬁc association of the individual complexes is represented
by the phospholipid milieu of the proteins; the individual
complexes are driven to interact by their high density in the
membrane bilayer. Since the amount of phospholipids in the
inner mitochondrial membrane is not bound to be naturally
modiﬁed to large extents, it is the lipid composition that may
have profound effects on the aggregation state. It was shown
that cardiolipin (CL) is speciﬁcally required for super-complex
association. Studies in a CL-lacking yeast mutant (Δcrd1 null
in expression of CL synthase) demonstrated that the III2–
IV2 super-complex was signiﬁcantly less stable than super-
complexes in the parental strain [36,37]. The putative direct
protein–protein interaction of cytochrome oxidase and Com-
plex III in yeast [37] is proposed to involve CL and phosphatidyl
ethanolamine, tightly bound in a cavity of the membrane
imbedded domain of Complex III [38], suggesting that they can
provide a ﬂexible linkage between the interacting subunits of
Complexes III and IV. Since yeast lacks Complex I, these studies
could not provide direct evidence on the super-complex I–III.
However, it was later found [39] that the cardiolipin deﬁciency
in Barth syndrome results in destabilization of the super-
complexes by weakening the interactions between respiratory
complexes. Digitonin extraction revealed a more labile super-
complex I1III2IV1 in mitochondria from Barth syndrome cells,
with Complex IV dissociating more readily from the super-
complex. The interaction between Complexes I and III was also
less stable, with decreased levels of the super-complex I1III2.
In particular, the effect of lipid peroxidation on super-complex
dissociation opens interesting perspectives in relation to
pathological changes where oxidative stress has an important
role (see Section 7).
(b) Electron transfer fromNADH to cytochrome c does not require the
association of the two complexes in a single super-complex, at
least in the reconstituted system we have exploited. In fact
NADH–cytochrome c reductase activity can be operative both
under conditions when complexes I and III are largely associated
in a super-complex (low phospholipid content) and when they
are mostly randomly dispersed (high phospholipid content).
Under the latter condition, kinetic analysis reveals that the pool
equation [31] is strictly obeyed, i.e. electron transfer is dictatedby
randomcollisionsof CoQwith its redoxpartners (CoQoxidizedwith
Complex I and CoQreducedwith Complex III) (cf. [24] for a detailed
analysis of the implications of the pool behavior of CoQ).
(c) Nevertheless, super-complex formation between Complex I
and Complex III provides a kinetic advantage, shown by the
demonstration of direct channeling between the complexes via
CoQ bymetabolic ﬂux control analysis and by direct calculation
that the rate of NADH–cytochrome c reductase is indeed higher
than predicted by the pool equation.
These ﬁndings provide indirect evidence on the beneﬁcial effects
of exogenous CoQ10 administration to humans affected by cardiovas-
cular and neurodegenerative diseases (cf Section 7): in fact the loss of
super-complex organization accompanied by loss of efﬁciency in
electron transfer in the CoQ region may be overcome by an excess of
CoQ in the membrane lipids after forced resumption of pool behavior
and random collisions. It is worth remembering that previous studies
in CoQ-depleted mitochondria [40] showed that the physiological
Fig. 2. Supramolecular organization of the NADH–cytochrome c oxidoreductase system in proteoliposomes. The presence of high molecular weight protein assemblies (SC,
supercomplexes) comprising Complex I and Complex III was investigated in proteoliposomes enriched with different amounts of phospholipids, i.e. 1:1 (left) and 1:30 (right)
protein:phospholipid ratio (w:w). Fraction R4B from bovine heart mitochondria was fused with phospholipids (Asolectin) and Coenzyme Q10 by cholate dilution [30]. The digitonin-
solubilized protein samples were analyzed by 2D BN/SDS-PAGE followed by Western blotting and chemiluminescent immunodetection using monoclonal primary antibodies
(MitoSciences Inc., Eugene, OR, USA) speciﬁc for the NDUFA9 (39 kDa) subunit of Complex I and for the Rieske protein subunit of Complex III. The mean values of NADH–cytochrome
c oxidoreductase activity in the two experimental samples (expressed in nanomoles of NADHmin−1 mg protein−1) and the corresponding ﬂux control coefﬁcients of Complex I and
Complex III are reported at the bottom of the ﬁgure.
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Complex I and Complex III.
5. Role of super-complexes in stability and assembly of Complex I
The ﬁrst chromatographic isolation of a complete respirasome
(I1III4IV4) from digitonin-solubilized membranes of Paracoccus deni-
triﬁcans indicated that Complex I is stabilized by assembly into the
respirasome since attempts to isolate Complex I from mutant strains
lacking complexes III or IV led to the complete dissociation of Complex
I under the conditions of BN-PAGE. Reduced stability of Complex I in
those mutant strains was also apparent from an almost complete loss
of NADH–ubiquinone oxidoreductase activity when the same protocol
as for parental strain was applied [41].
Analysis of the state of super-complexes in human patients with
an isolated deﬁciency of single complexes [42] and in cultured cell
models harboring cytochrome b mutations [43,44] also provided
evidence that the formation of respirasomes is essential for the
assembly/stability of Complex I. Genetic alterations leading to a loss
of Complex III prevented respirasome formation and led to secondary
loss of Complex I, therefore primary Complex III assembly deﬁcienciespresented as Complex III/I defects. Conversely, Complex III stability
was not inﬂuenced by the absence of Complex I.
Several other studies in mutants and patients having speciﬁc
defects in a single respiratory complex have suggested that Complex
III and to a lesser extent Complex IV are involved in the assembly and
stabilization of Complex I in mammals [39,45,46].
6. A role of super-complex I–III organization on limiting
ROS formation?
The suggestion that loss of super-complex organization induces
excessive ROS formation has been advanced [23,47] although no
speciﬁc study has been yet directed to this purpose.
Indirect evidence dealing with this hypothesis originates from
studies on superoxide generation by Complex I. It has been discussed
that two potential sites for oxygen reduction exist in Complex I,
represented by FMN and iron–sulfur cluster N2.
The ﬁndings in our laboratory that two different classes of inhibi-
tors have opposite effects on oxygen reduction to superoxide during
forward electron transfer together with other observations, allowed
us to draw a tentative scheme of electron transfer in Complex I [48].
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pathway of electrons along the series of iron–sulfur clusters as
demonstrated by the crystallographic study of Sazanov [49]: our
interpretation is not in contrast with the existence of a linear pathway,
because the two electrons delivered to CoQ for its complete reduction
could be provided by the same cluster (N2) consecutively, if a suitable
conformational change occurs after the ﬁrst electron delivery in order
to provide a gatingmechanism for the second electron. Table 1 exhibits
themain properties of Complex I induced by an inhibitor of each of the
two classes in relation to ROS production.
On the other hand, in isolated Complex I, FMN is considered the
major electron donor to oxygen to form superoxide anion [50,51] also
mediated by short chain hydrophilic quinones [52]. A possible expla-
nation is that two sites for oxygen reduction exist in the complex,
represented by both ﬂavin and an iron–sulfur cluster; the latter site
would be predominant in membrane particles whereas the former
might be available after Complex I isolation. Hirst et al. [53] admit the
possible presence of two oxygen-reacting sites at the two ends of the
cofactor chain, ascribing the distal one to superoxide generation
during reverse electron transfer.
We have also indicated that N2 as a source of ROS would be
predominant in membrane particles whereas FMN might become
available after Complex I isolation [54]. A reasonable hypothesis is
that FMN becomes exposed to oxygen only when Complex I is disso-
ciated from Complex III and it is suggestive to postulate that a looser
organization of the respiratory enzymes enhances ROS production,
although no direct study is still available to exclude that the observed
variations have to be ascribed to sample manipulation or to differ-
ences occurring in the lipid environment of the complexes. The
molecular structure of the individual complexes does not allow to
envisage a close apposition of the matrix arm of Complex I, where
FMN is localized, with either Complex III or IV (see Section 2), but the
actual shape of the I1III2IV1 super-complex from bovine heart [18]
suggests a slightly different conformation of Complex I in the super-
complex, showing a higher bending of the matrix arm towards the
membrane (and presumably Complex III), in line with the notion that
Complex I may undergo important conformational changes [55].
Moreover, the observed destabilization of Complex I in the absence of
a super-complex [43,44] may render the 51 kDa subunit containing
the FMN more “loose” allowing it to interact with oxygen. The
elevated ROS production observed in Podospora anserina respiring on
the alternative oxidase, where the major form of Complex I is a I2III2
super-complex rather than the usual I1III2 super-complex [56], is in
line with this reasoning, because it is likely that the Complex I dimer
may undergo a less tight interaction than a Complex I monomer
with the Complex III dimer. On the basis that ROS production by NAD-
dependent respiration in rat brain mitochondria is at minimum and is
not affected by the energy state of the mitochondria, Panov et al.
also supported the idea that respiratory super-complexes comprising
Complex I are evolutionary adaptive mechanisms designed to
increase the efﬁciency of substrate utilization and to prevent exces-
sive generation of ROS [57]. Examples of pathological states where an
elevated production of ROS accompanies super-complex disorgani-Table 1
ROS generation and properties of Complex I in bovine heart submitochondrial particles
treated with two classes of inhibitors. The two classes are represented by rotenone and
stigmatellin, respectively. Cf. ref [48] for experimental details and for a model of
electron transfer from iron–sulfur cluster N2 to CoQ deriving from the experiments
described (see Tab. 8 in ref [48]). The symbols + and− indicate presence and absence,
respectively. Ox, oxidized; red, reduced.
Complex I
inhibition
ROS
generation
CoQ
semiquinone
N2 redox
state
Control 0 − + Ox
Rotenone 100% + − Red
Stigmatellin 100% − + Oxzation, reported in Section 7 of this review, are also in line with the
proposal.7. Super-complexes and pathology
An overwhelming body of evidence accumulated in the last
decades has demonstrated that mitochondria have a central role in
the development of the aging process and in the etiology and patho-
genesis of most major chronic diseases [58–65]; the involvement of
mitochondria in disease, that has generated the term “Mitochondrial
Medicine” [66], has been ascribed to their central role in production of
ROS and to the damaging effect of ROS on these organelles. In partic-
ular, damage to mitochondrial DNA (mtDNA) would induce altera-
tions of the polypeptides encoded by mtDNA in the respiratory
complexes, with consequent decrease of electron transfer activity,
leading to further production of ROS, and thus establishing a vicious
circle of oxidative stress and energetic decline [67,68]. This fall of
mitochondrial energetic capacity is considered to be the cause of
aging and age-related degenerative diseases [60,62,69,70], although
the picture is further complicated by the complex interplay and cross-
talk with nuclear DNA and the rest of the cell [71,72]. This vicious
circle might be broken by agents capable of preventing a chain reac-
tion of ROS formation and damage, such as CoQ in its reduced form
[73].
Moreover, evidences are accumulating in the literature that super-
complexes are altered in some pathological cases related to oxidative
stress and mitochondrial dysfunction: it is easy to foresee a deep
implication of super-complex organization as a missing link between
oxidative stress and energy failure [23]. As depicted in the scheme in
Fig. 3, it is tempting to speculate that oxidative stress induces disso-
ciation of Complex I–III interactions, with loss of facilitated electronFig. 3. Effect of super-complex disorganization on mitochondrial function. Membrane
phospholipid peroxidation and consequent loss of super-complex organization may
occur following an oxidative stress induced by genetic changes (i.e. mitochondrial DNA
mutations) or by exogenous factors (i.e. ischemia and reperfusion); the ensuing
destabilization of Complex I results in OXPHOS deﬁciency and further oxidative stress.
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free ubiquinone molecules.
In such regard, the loss of efﬁcient electron transfer observed in
experimental heart failure together with the loss of super-complex
organization [74] appears as a clear indication of the deleterious
consequence of lack of supramolecular organization.
A recent study on human neutrophil mitochondria [75] also clearly
points out the consequences of lack of super-complex organization. In
neutrophils, mitochondria are present but their respirationwith NAD-
linked substrates is not apparently used for ATP synthesis; the activity
of individual complexes is present although rather low for complexes
I, III, and IV; it was shown that the individual complexes were present
only in a non-assembled form with the complete absence of super-
complex organization. On the other hand, the super-complexes are
present in the myeloid cell line HL-60, but during differentiation to
neutrophil-like cells, HL-60 lose super-complex organization with
consequent lack of respiration.
Similarly clear indications were obtained in the cited study [74] on
canine cardiac mitochondria in heart failure induced experimentally
by micro-embolization. Although the activity of individual complexes
I, III and IV was normal, respiration with NAD-linked substrates in
State 3 or after treatment with an uncoupler was severely affected;
BN-PAGE showed a similar severe reduction of supramolecular orga-
nizationwith particular decrease of themajor I1III2IV1 super-complex.
Clearly the OXPHOS defect was to be ascribed to alteration of the
supramolecular assembly rather than to the individual components of
the respiratory chain; the reason for such diminished assembly was
not discussed in the paper by Rosca et al. [74], although it is tempting
to speculate that enhanced ROS production due to ischemia and
reperfusion in the micro-embolized vessels modiﬁes the membrane
environment as a consequence of lipid peroxidation, thus disrupting
super-complex assembly.
A very recent study in aged rat heart [76] showed by BN-PAGE and
proteomic analysis that super-complexes decline with age, although
the amounts of individual complexes stay steady. This ﬁnding mayFig. 4. ROS generation and super-complex organization of K-ras-transformed ﬁbroblas
Representative images (magniﬁcation 20×) of control (A) and K-ras-transformed cells (B) in
in control (C) and K-ras-transformed cells (D) was achieved by 2D electrophoretic separ
single subunits of each respiratory complex. a, monomeric Complex I. Protein bands of molec
IV; c, I+III: super-complex formed by Complex I and III; d, I+III +IV super-complex formeprovide a rationale to the observed decline in respiration and ATP
synthesis during aging [62].
Further evidence on the role of super-complex disruption in
pathology is provided by a recent study from our laboratory on K-ras-
transformed ﬁbroblasts [77].
In order to critically analyze the molecular basis of the change of
carbon metabolism in cancer cells, we compared two cell lines that
have been previously characterized [78,79], that is NIH3T3 mouse
ﬁbroblasts and NIH3T3 cells transformed by an activated form of the
K-ras oncogene. Ras proteins are intracellular switches whose activa-
tion state (i.e. their binding to GDP or GTP) controls downstream
pathways leading to cell growth and differentiation. Mutation of the
ras gene is a critical event in the onset of different malignant pheno-
types [80]. Cells harboring K-rasmutations were consistently found to
have an increased expression of the glucose transporter GLUT1 and an
enhanced glycolytic rate, presumably as a compensation to glucose
deprivation [81]. We showed that the major phenotypic change of
transformed ﬁbroblasts is a dramatic loss of activity and content of
respiratory Complex I (50% approx.), resulting in a strong decrease of
both NAD-linked respiration and ATP synthesis rate [77]. Accordingly,
a signiﬁcant change in the expression of several genes encoding
subunits of the mitochondrial OXPHOS complexes, and in particular a
decrease of Complex I, was observed in neoplastic cells.
It has been discussed in Section 5 that Complex I is unstable and
becomes disassembled in the absence of super-complex organization.
To this purpose, it was evident from 2D-electrophoresis (Fig. 4C,D)
that the low residual amount of Complex I in transformedﬁbroblasts is
mostly in an isolated form rather than assembledwith Complex III and
Complex IV in high molecular weight super-complexes. In particular,
the larger super-complex detected in control cells is almost absent in
ras-transformed ﬁbroblasts. In addition, ras-transformed ﬁbroblasts
also have an enhanced production of ROS [79] (cf. Fig. 4A,B). In the
previous section of this review (Section 6)we have discussed evidence
that enhanced ROS generation induces dissociation of the I–III super-
complex with consequent lack of efﬁcient electron channeling fromts. Left side. Fluorescence microscopy images of MitoSOX Red loaded ﬁbroblasts.
cubated with 4 µMMitoSOX Red for 10 min at 37 °C. Right side. Super-complex analysis
ation and immunodetection by using a cocktail of monoclonal antibodies speciﬁc for
ular mass above 1000 kDa are: b, I+III+IV: super-complex formed by Complex I, III and
d by complex I, III, and IV.
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Complex I assembly induced by super-complex dissociation (Section 5)
might also account for the decrease of NAD-linked respiration and ATP
synthesis. The OXPHOS dysfunction in K-ras-transformed cells might
then lead to compensatory enhancement of glycolysis to overcome the
energetic deﬁciency.
Several other observations from the literaturemay ﬁnd a reasonable
explanation in the existence of super-complexes and their pathological
alterations. The lossof Complex I content andactivity reported in several
pathological conditions accompanied by oxidative stress, such as
Parkinson's disease [82], schizophrenia [83], non-alcoholic fatty liver
[84], aging [85,86], ischemia and reperfusion [87], and diabetes [88,89]
should be investigated in terms of organization of the respiratory chain.
The involvement of cardiolipin oxidation reported in some of these
changes [84,86,87] further strengthens this hypothesis. In a cell line
obtained from a thyroid oncocytoma, although a strong decrease of
Complex I activity is a likely direct consequence of a point mutation in
the mitochondrial gene for Complex I subunit ND1 [90], both the
presence of a concomitant heteroplasmic mutation in cytochrome b
of Complex III and an extremely high ROS production together with
loss of super-complex organization were also noticed [35,90], in line
with the above working hypothesis.
Super-complex organization should be also discussed in terms of
therapeutic interventions [22].
Strong evidence exists that exogenous CoQ10 administration is
beneﬁcial in several disease states, e.g. in genetic CoQ10 deﬁciency
[91,92], cardiac failure [93], Parkinson's disease [94–96] and Friedreich
ataxia [97]. There is evidence,mainly indirect, that orally administered
CoQ10 may be incorporated into mitochondria, at least in conditions of
partial CoQ tissue deﬁciency, where it may enhance electron transfer
and ATP synthesis, besides exerting an antioxidant effect in its reduced
form.
The existence of I–III super-complexes where only inter-complex
bound CoQ is active by channeling electrons from Complex I to
Complex III is apparently incompatible with a dose-dependent effect
of added CoQ10, but the notion that inter-complex bound CoQ is in
chemical equilibrium with CoQ in the pool [24] may explain the
improved cell bioenergetics upon addition of exogenous CoQ10.
Nevertheless, the increasing evidence previously discussed in this
section that super-complex assembly may be disrupted under
several pathological conditions, and the demonstration that electron
transfer between Complex I and Complex III may occur through CoQ-
pool behavior, also discussed in this review, suggest that the beneﬁcial
effect of exogenous CoQ10 may be in supporting electron transfer by
collision-mediated interactions when channeling within the super-
complex is hampered.References
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